A life sciences company needs to rely on more than historical prescription volume to ensure product success in today’s hypercompetitive marketplace. Partner Dan Wetherill and Vice President Janardhan Vellore describe in Pharmaceutical Executive how life sciences companies can proactively increase the breadth and depth of prescriptions to propel brand performance.
Read Full Article